ebomi
Colour theme
Sign in
Insider · CIK 0001633584

Armistice Capital Master Fund Ltd.

CIK 0001633584 Name as filed on the most recent filing

Filed as Armistice Capital Master Fund Ltd. (191)

1,268 transaction lines · from 191 filings · filed 2017-05-09 to 2023-06-28 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2020-05-05 S, Open-market sale Vaxart, Inc.VXRT 1,842,132, disposed Open Form 4 filing 0000919574-20-003147
2020-05-05 S, Open-market sale Vaxart, Inc.VXRT Not reported Open Form 4 filing 0000919574-20-003147
2020-05-04 S, Open-market sale Vaxart, Inc.VXRT 2,537,293, disposed Open Form 4 filing 0000919574-20-003147
2020-05-04 S, Open-market sale Vaxart, Inc.VXRT Not reported Open Form 4 filing 0000919574-20-003147
2020-05-01 S, Open-market sale Vaxart, Inc.VXRT 2,710,000, disposed Open Form 4 filing 0000919574-20-003147
2020-05-01 S, Open-market sale Vaxart, Inc.VXRT Not reported Open Form 4 filing 0000919574-20-003147
2020-04-30 S, Open-market sale Vaxart, Inc.VXRT 13,125,516, disposed Open Form 4 filing 0000919574-20-003105
2020-04-30 S, Open-market sale Vaxart, Inc.VXRT Not reported Open Form 4 filing 0000919574-20-003105
2020-04-29 S, Open-market sale Vaxart, Inc.VXRT 2,629,638, disposed Open Form 4 filing 0000919574-20-003105
2020-04-29 S, Open-market sale Vaxart, Inc.VXRT Not reported Open Form 4 filing 0000919574-20-003105
2020-04-28 S, Open-market sale Vaxart, Inc.VXRT 4,367,197, disposed Open Form 4 filing 0000919574-20-003105
2020-04-28 S, Open-market sale Vaxart, Inc.VXRT Not reported Open Form 4 filing 0000919574-20-003105
2020-04-27 S, Open-market sale Aytu Bioscience, IncAYTU 9,298,236, disposed Open Form 4 filing 0000919574-20-003060
2020-04-27 S, Open-market sale Aytu Bioscience, IncAYTU Not reported Open Form 4 filing 0000919574-20-003060
2020-04-03 P, Open-market purchase Cerecor Inc.CERC 9,245, acquired Open Form 4 filing 0000919574-20-002783
2020-03-31 P, Open-market purchase Cerecor Inc.CERC 62,004, acquired Open Form 4 filing 0000919574-20-002662
2020-03-30 P, Open-market purchase Cerecor Inc.CERC 115,862, acquired Open Form 4 filing 0000919574-20-002662
2020-03-27 P, Open-market purchase Cerecor Inc.CERC 87,480, acquired Open Form 4 filing 0000919574-20-002662
2020-03-23 P, Open-market purchase Cerecor Inc.CERC 3,462, acquired Open Form 4 filing 0000919574-20-002556
2020-03-20 P, Open-market purchase Cerecor Inc.CERC 24,065, acquired Open Form 4 filing 0000919574-20-002556
2020-03-19 P, Open-market purchase Cerecor Inc.CERC 4,074, acquired Open Form 4 filing 0000919574-20-002505
2020-03-18 P, Open-market purchase Cerecor Inc.CERC 2 lines 54,307, acquired Open Form 4 filing 0000919574-20-002505
2020-03-17 P, Open-market purchase Cerecor Inc.CERC 3,999,999, acquired Open Form 4 filing 0000919574-20-002505
2020-03-17 P, Open-market purchase Cerecor Inc.CERC Not reported Open Form 4 filing 0000919574-20-002505
2020-03-16 P, Open-market purchase Amag Pharmaceuticals, Inc.AMAG 116,880, acquired Open Form 4 filing 0000919574-20-002488
2020-03-10 S, Open-market sale Aytu Bioscience, IncAYTU 28,767,869, disposed Open Form 4 filing 0000919574-20-002393
2020-03-10 S, Open-market sale Aytu Bioscience, IncAYTU 2,432,254, disposed Open Form 4 filing 0000919574-20-002393
2020-03-10 S, Open-market sale Aytu Bioscience, IncAYTU Not reported Open Form 4 filing 0000919574-20-002393
2020-03-10 S, Open-market sale Aytu Bioscience, IncAYTU Not reported Open Form 4 filing 0000919574-20-002393
2020-02-25 P, Open-market purchase Amag Pharmaceuticals, Inc.AMAG 2 lines 298,440, acquired Open Form 4 filing 0000919574-20-002015
2020-02-10 P, Open-market purchase Eyegate Pharmaceuticals IncEYEG 72,480, acquired Open Form 4 filing 0000919574-20-000888
2020-02-10 P, Open-market purchase Eyegate Pharmaceuticals IncEYEG Not reported Open Form 4 filing 0000919574-20-000888
2020-02-06 P, Open-market purchase Eyegate Pharmaceuticals IncEYEG 67,980, acquired Open Form 4 filing 0000919574-20-000888
2020-02-06 P, Open-market purchase Eyegate Pharmaceuticals IncEYEG Not reported Open Form 4 filing 0000919574-20-000888
2020-02-03 P, Open-market purchase Cerecor Inc.CERC 3,905,502, acquired Open Form 4 filing 0000919574-20-000751
2020-02-03 P, Open-market purchase Cerecor Inc.CERC 1,094,500, acquired Open Form 4 filing 0000919574-20-000751
2020-02-03 P, Open-market purchase Cerecor Inc.CERC Not reported Open Form 4 filing 0000919574-20-000751
2020-01-29 P, Open-market purchase ReShape Lifesciences Inc.RSLS 14,900, acquired Open Form 4 filing 0000919574-20-000682
2020-01-29 P, Open-market purchase ReShape Lifesciences Inc.RSLS 6,490, acquired Open Form 4 filing 0000919574-20-000682
2020-01-29 P, Open-market purchase ReShape Lifesciences Inc.RSLS Not reported Open Form 4 filing 0000919574-20-000682
2020-01-29 P, Open-market purchase ReShape Lifesciences Inc.RSLS Not reported Open Form 4 filing 0000919574-20-000682
2020-01-27 P, Open-market purchase Amag Pharmaceuticals, Inc.AMAG 75,440, acquired Open Form 4 filing 0000919574-20-000618
2020-01-27 P, Open-market purchase Amag Pharmaceuticals, Inc.AMAG 75,280, acquired Open Form 4 filing 0000919574-20-000618
2020-01-27 P, Open-market purchase Amag Pharmaceuticals, Inc.AMAG Not reported Open Form 4 filing 0000919574-20-000618
2020-01-24 P, Open-market purchase Amag Pharmaceuticals, Inc.AMAG 388,800, acquired Open Form 4 filing 0000919574-20-000618
2020-01-24 P, Open-market purchase Amag Pharmaceuticals, Inc.AMAG 325,720, acquired Open Form 4 filing 0000919574-20-000618
2020-01-24 P, Open-market purchase Amag Pharmaceuticals, Inc.AMAG Not reported Open Form 4 filing 0000919574-20-000618
2020-01-10 P, Open-market purchase Amag Pharmaceuticals, Inc.AMAG 209,520, acquired Open Form 4 filing 0000919574-20-000323

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. Armistice Capital Master Fund Ltd., insider transactions. Retrieved 2026-08-25 from https://ebomi.com/insider/0001633584

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.